Comorbidity Profile Among Patients with Rheumatoid Arthritis and the Impact on Prescriptions Trend

被引：30

作者：

Al-Bishri, J. ^{[1
]}

Attar, S. M. ^{[2
]}

Bassuni, Nawal ^{[3
]}

Al-Nofaiey, Yasser ^{[4
]}

Qutbuddeen, Hamed ^{[4
]}

Al-Harthi, Salma ^{[4
]}

Subahi, Sarah ^{[4
]}

机构：

[1] Taif Univ, Dept Internal Med, POB 11153, At Taif, Saudi Arabia

[2] King Abdulaziz Univ, Dept Internal Med, Jeddah, Saudi Arabia

[3] King Abdul Aziz Med City, Dept Internal Med, Jeddah, Saudi Arabia

[4] SCFHS Ctr, Dept Clin Med, Jeddah, Saudi Arabia

来源：

CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS | 2013年 / 6卷

关键词：

rheumatoid arthritis; comorbidity; hypertension; diabetes; RA; NSAIDs; glucocorticoids;

D O I：

10.4137/CMAMD.S11481

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

Comorbid conditions play a pivotal role in rheumatoid arthritis management and outcomes. We estimated the percentage of comorbid illness among rheumatoid arthritis patients and explored the relationship between this comorbidity and different prescriptions. A cross-sectional study of patients with rheumatoid arthritis in three centers in Saudi Arabia was carried out. Comorbidity and antirheumatoid medication regimens prescribed were recorded on a specially designed Performa. The association between comorbidity and different drugs was analyzed. A total of 340 patients were included. The most comorbidities were hypertension 122 (35.9%), diabetes 105 (30.9%), osteoporosis 88 (25.8%), and dyslipidemia in 66 (19.4). The most common drug prescribed was prednisolone in 275 (80.8%) patients followed by methotrexate in 253 (74.4%) and biological therapy in 142 (41.5%) patients. Glucocorticoids were prescribed considerably more frequently in hypertensive and diabetic patients as well as in patients with osteoporosis and dyslipidemia. Most patients with rheumatoid arthritis suffered from comorbid diseases.

引用

页码：11 / 18

页数：8

共 46 条

[1]

Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor α therapy [J].

Antohe, Jana L. ;

Bili, Androniki ;

Sartorius, Jennifer A. ;

Kirchner, H. Lester ;

Morris, Stephanie J. ;

Dancea, Sorina ;

Wasko, Mary Chester M. .

ARTHRITIS CARE & RESEARCH, 2012, 64 (02) :215-221

[2]

THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[3]

Boon NA, 2009, DAVIDSONS PRINCIPLES, P1101

[4]

Autoimmune Thyroid Disease in Rheumatoid Arthritis: A Global Perspective [J].

Cardenas Roldan, Jorge ;

Amaya-Amaya, Jenny ;

Castellanos-de la Hoz, Juan ;

Giraldo-Villamil, Juliana ;

Montoya-Ortiz, Gladys ;

Cruz-Tapias, Paola ;

Rojas-Villarraga, Adriana ;

Mantilla, Ruben D. ;

Anaya, Juan-Manuel .

ARTHRITIS, 2012,

[5]

Importance of Patient History and Physical Examination in Rheumatoid Arthritis Compared to Other Chronic Diseases: Results of a Physician Survey [J].

Castrejon, Isabel ;

McCollum, Lauren ;

Tanriover, Mine Durusu ;

Pincus, Theodore .

ARTHRITIS CARE & RESEARCH, 2012, 64 (08) :1250-1255

[6]

Cojocaru Manole, 2010, Maedica (Bucur), V5, P286

[7]

Cuccurullo S., 2004, PHYS MED REHABILITAT

[8]

Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective [J].

De Keyser, Filip .

CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (01) :77-87

[9]

Ebringer Alan, 2009, Front Biosci (Elite Ed), V1, P577

[10]

EFFECT OF SHORT-TERM, LOW-DOSE CORTICOSTEROIDS ON PLASMA-LIPOPROTEIN LIPIDS [J].

ETTINGER, WH ;

KLINEFELTER, HF ;

KWITEROVITCH, PO .

ATHEROSCLEROSIS, 1987, 63 (2-3) :167-172

← 1 2 3 4 5 →